Antoxerene
Biotech company developing small molecule drugs that target protein pathways related to aging
This is a pharmaceutical company that uses proprietary next generation screening technology to identify small molecule drugs for pathways of aging. It is an affiliate of Ichor Therapeutics. Antoxerene is eager to engage collaborators in industry and academia who share its vision of delivering next generation therapies for the illnesses of aging.
Visit website: https://antoxerene.com/
Details last updated 03-May-2019
Antoxerene News
FoxBio is developing small molecule drugs to target ageing diseases
Business Wire - 12-Jul-2018
Antoxerene partners with Juvenescence to discover drugs that clear senescent cells
Read more...